Gradual Increase in Hematologic Malignancy in Korea from 2005 to 2015 Based on the National Health Insurance Service Data
10.3343/lmo.2020.10.2.144
- Author:
Yujin HAN
1
;
Young Jin KIM
;
Min Jin KIM
;
Ja Min BYUN
;
Taemi YOUK
;
Hoi Soo YOON
;
Jae Hee LEE
;
Woo-In LEE
;
Tae Sung PARK
;
Jongha YOO
Author Information
1. Department of Laboratory Medicine, Kyung Hee University School of Medicine, Seoul, Korea
- Publication Type:Original Article
- From:Laboratory Medicine Online
2020;10(2):144-151
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Hematologic malignancies have a relatively lower prevalence than major solid cancers, although the incidence of hematologic malignancies has significantly increased in recent years. However, understanding the current status of hematologic malignancy is significantly challenging because basic data regarding this malignancy are insufficient in the Korean population.
Methods:From 2005 to 2015, the status of seven codes of hematologic malignancy, containing 24 subcodes defined using a classification defined by the Korean Classification of Disease-6, was analyzed. The number of new patients, crude incidence rate, prevalence rate, and age-standardized incidence rate were also investigated. Results were analyzed based on National Health Insurance Service (NHIS) data.
Results:The number of new patients showed an overall increase over time and a rate of increase up to 56.7% for 10 years. The number of male patients was higher than that of female patients, with the majority of patients aged greater than 60 years. The incidence and prevalence rates have increased steadily.
Conclusions:Consistent with the previous studies, this study might be useful to understand the current status of hematologic malignancy and might contribute to the improvement of national public healthcare.
